C-Path’s Alzheimer’s Disease Consortium Expands Data Repository New patient-level data will facilitate more efficient clinical trial design TUCSON, Ariz., April 12, 2021 — The Critical Path In
C-Path Launches Acute Kidney Injury Project with Support from FDA Project aims to develop improved predictive and detection tools for kidney injury TUCSON, March 25, 2021 — Acute kidney injury (
C-Path Names COO Kristen Swingle Interim President Joseph Scheeren departing the organization after two years of strong leadership TUCSON, Ariz., March 19, 2021 — Critical Path In
C-Path Program and Consortia Leaders Selected to Serve in Sr. Vice President and Vice President Roles Inish O’Doherty and Sudhir Sivakumaran will lead new programs; Stephen Joel Coons and John-Michael Sauer move into Sr. VP roles.
C-Path Receives FDA Qualification for the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) TUCSON, Ariz., March 9, 2021 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces the
C-Path and Global Partners Launch Ataxia Consortium The Critical Path to Therapeutics for the Ataxias will optimize clinical trials for inherited ataxias TUCSON, Ariz., Febru
C-Path Appoints Co-Directors to CURE Drug Repurposing Collaboratory Advisory Committee TUCSON, Ariz., February 4, 2021 — Critical Path Institute (C-Path) today has announced the appointments of David F
C-Path Announces SHIP-MD 2021 Virtual Workshop Multi-stakeholder event will focus on national innovation ecosystem for pediatric medical device development TUCSON, Ariz.,
Diary for Irritable Bowel Syndrome Symptoms-Constipation is the First Patient-Reported Outcome Consortium Measure Used to Support an FDA-approved Label Claim TUCSON, Ariz., January 7, 2021 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces th
C-Path and Diamyd Medical Announce Data Sharing Collaboration to Develop Advanced Drug Development Tools in Type 1 Diabetes TUCSON, Ariz., and STOCKHOLM, Sweden. December 16, 2020 — The Critical Path Institute (C-Path) and Diamyd Medical